In a collaboration effort to test whether existing drug candidates block infection from respiratory pathogens like SARS-CoV-2, researchers from the Wyss Institute at...
After several weeks of no coverage, hydroxychloroquine is now back in the news. COPCOV is a double-blind, randomized, placebo-controlled trial that is planned for...
JHVEPhoto/Shutterstock While the U.S. and the world have largely fast-tracked efforts to develop a vaccine against COVID-19, experts in the field of...
As the coronavirus pandemic hits more impoverished countries with fragile health care systems, global health authorities are scrambling for supplies of a simple...
The health ministry on Friday reported 54,771 new cases, a record daily spike that brought the nationwide total to 1,032,913.The Covid-19 pandemic is...
Back in March we told you about hydroxychloroquine after the Food and Drug Administration (FDA) issued emergency use authorization of anti-malaria drug Hydroxychloroquine for treatment...
The neuromuscular disorder, Myasthenia Gravis, causes weakness in the skeletal muscles the body uses for movement. It happens because the communication between...
